Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Harrow Health Inc

HROW
Current price
30.42 USD -1.53 USD (-4.79%)
Last closed 30.89 USD
ISIN US4158581094
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 304 922 624 USD
Yield for 12 month +185.10 %
1Y
3Y
5Y
10Y
15Y
HROW
21.11.2021 - 28.11.2021

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. Further, the company has collaboration with Asembia to enhance provider and patient experience through nationwide digital services and hub support for harrow's branded eyecare products. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee. Address: 102 Woodmont Boulevard, Nashville, TN, United States, 37205

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

59.85 USD

P/E ratio

Dividend Yield

Current Year

+130 193 000 USD

Last Year

+88 595 000 USD

Current Quarter

+49 257 000 USD

Last Quarter

+48 939 000 USD

Current Year

+90 553 000 USD

Last Year

+63 212 000 USD

Current Quarter

+37 239 000 USD

Last Quarter

+36 400 000 USD

Key Figures HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 2 738 000 USD
Operating Margin TTM 2.68 %
PE Ratio
Return On Assets TTM -1.68 %
PEG Ratio
Return On Equity TTM -50.23 %
Wall Street Target Price 59.85 USD
Revenue TTM 169 138 000 USD
Book Value 1.64 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 43.80 %
Dividend Yield
Gross Profit TTM 63 212 000 USD
Earnings per share -0.95 USD
Diluted Eps TTM -0.95 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -64.00 %
Profit Margin -19.75 %

Dividend Analytics HROW

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:5
Payout Ratio
Last Split Date 08.02.2013
Dividend Date
Consecutive Years
Consistent Years
Continuous Dividends

Stock Valuation HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 8.45
Price Sales TTM 7.72
Enterprise Value EBITDA 1 341.21
Price Book MRQ 22.51

Financials HROW

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HROW

For 52 weeks

9.13 USD 59.23 USD
50 Day MA 46.28 USD
Shares Short Prior Month 2 507 664
200 Day MA 28.92 USD
Short Ratio 4.56
Shares Short 2 870 563
Short Percent 11.40 %